374505213	374505213	CD	B-NP	O
|	|	NN	I-NP	O
AMH	AMH	NN	I-NP	O
|	|	NN	I-NP	O
30420782	30420782	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4271162	4271162	CD	B-NP	O
|	|	CC	I-NP	O
7/26/2007	7/26/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
right	right	JJ	I-NP	O
femur	femur	NN	I-NP	O
fracture	fracture	NN	I-NP	O
|	|	NN	I-NP	O
Unsigned	Unsigned	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/27/2007	10/27/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/27/2007	5/27/2007	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
MIDGET	MIDGET	NN	B-NP	O
,	,	,	O	O
IRA	IRA	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Hip	Hip	NN	B-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
hip	hip	NN	I-NP	O
surgery	surgery	NN	I-NP	O
and	and	CC	O	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
see	see	VB	I-VP	O
original	original	JJ	B-NP	O
dictation	dictation	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
present	present	JJ	B-NP	O
illness	illness	NN	I-NP	O
,	,	,	O	O
past	past	JJ	B-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
medications	medication	NNS	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
allergies	allergy	NNS	B-NP	O
,	,	,	O	O
social	social	JJ	B-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
physical	physical	JJ	B-NP	O
exam	exam	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
EKG	EKG	NN	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
all	all	DT	B-NP	O
data	datum	NNS	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
also	also	RB	B-ADVP	O
see	see	VBP	B-VP	O
that	that	IN	B-SBAR	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
only	only	RB	B-ADVP	O
goes	go	VBZ	B-VP	O
from	from	IN	B-PP	O
August	August	NNP	B-NP	O
through	through	IN	B-PP	O
3/24/07	3/24/07	CD	B-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

Orthopedics	Orthopedic	NNS	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
update	update	NN	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
orthopedics	orthopedics	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
his	his	PRP$	B-NP	O
heparin	heparin	NN	I-NP	B-protein
5000	5000	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
following	follow	VBG	B-PP	O
his	his	PRP$	B-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
7/11/07	7/11/07	CD	B-NP	O
,	,	,	O	O
so	so	IN	O	O
he	he	PRP	B-NP	O
just	just	RB	B-ADVP	O
about	about	IN	I-ADVP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
this	this	DT	B-NP	O
one	one	CD	I-NP	O
month	month	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
Ultram	Ultram	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
twelve	twelve	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
narcotics	narcotic	NNS	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
avoided	avoid	VBN	I-VP	O
as	as	IN	B-SBAR	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
in	in	IN	B-PP	O
severe	severe	JJ	B-NP	O
delirium	delirium	NN	I-NP	O
for	for	IN	B-PP	O
Mr.	Mr.	NNP	B-NP	O
Puotinen	Puotinen	NNP	I-NP	O
No	No	NNP	I-NP	O
update	update	NN	I-NP	O
to	to	TO	B-PP	O
cardiovascular	cardiovascular	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
held	hold	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
between	between	IN	B-PP	O
100-110/60	100-110/60	CD	B-NP	O
-70	-70	CD	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
60s-70s	60s-70	NNS	I-NP	B-DNA
,	,	,	O	O
no	no	RB	B-ADVP	O
higher	high	JJR	I-ADVP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
80s	80	NNS	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
increases	increase	NNS	I-NP	O
,	,	,	O	O
starting	start	VBG	B-VP	O
Lopressor	Lopressor	NN	B-NP	O
again	again	RB	B-ADVP	O
at	at	IN	B-PP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	B-ADVP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
wise	wise	JJ	B-ADJP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
currently	currently	RB	B-ADVP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
high	high	JJ	B-ADJP	O
nor	nor	CC	O	O
does	do	VBZ	B-VP	O
his	his	PRP$	B-NP	O
rate	rate	NN	I-NP	O
require	require	VB	B-VP	O
this	this	DT	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
uptake	uptake	NN	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continued	continue	VBD	B-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
dialysis	dialysis	NN	I-NP	O
on	on	IN	B-PP	O
Tuesday	Tuesday	NNP	B-NP	O
,	,	,	O	O
Thursday	Thursday	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Saturdays	Saturday	NNS	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
also	also	RB	B-ADVP	O
got	get	VBD	B-VP	O
dialysis	dialysis	NN	B-NP	O
on	on	IN	B-PP	O
Friday	Friday	NNP	B-NP	O
the	the	DT	B-NP	O
6	6	CD	I-NP	O
of	of	IN	B-PP	O
July	July	NNP	B-NP	O
since	since	IN	B-SBAR	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
today	today	NN	B-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
that	that	IN	I-SBAR	O
he	he	PRP	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
Monday	Monday	NNP	I-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Friday	Friday	NNP	B-NP	O
dialysis	dialysis	NN	I-NP	O
course	course	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Ans	Ans	NNP	I-NP	O
General	General	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
From	From	IN	B-PP	O
an	an	DT	B-NP	O
endocrine	endocrine	JJ	I-NP	O
perspective	perspective	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
remained	remain	VBD	B-VP	O
on	on	IN	B-PP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
only	only	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
Lantus	Lantus	NNP	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
update	update	NN	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
GI	GI	NN	I-NP	O
oncologic	oncologic	JJ	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Trimboli	Trimboli	NNP	I-NP	O
on	on	IN	B-PP	O
in	in	IN	B-PP	O
4/15/07	4/15/07	CD	B-NP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
:	:	SYM	O	O
00	00	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
From	From	IN	B-PP	O
a	a	DT	B-NP	O
delirium	delirium	NN	I-NP	O
perspective	perspective	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
Zyprexa	Zyprexa	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
after	after	IN	B-PP	O
his	his	PRP$	B-NP	O
sense	sense	NN	I-NP	O
of	of	IN	B-PP	O
delirium	delirium	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
cleared	clear	VBN	I-VP	O
for	for	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
he	he	PRP	B-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
start	start	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
sorts	sort	NNS	I-NP	O
of	of	IN	B-PP	O
hallucinations	hallucination	NNS	B-NP	O
or	or	CC	I-NP	O
issues	issue	NNS	I-NP	O
with	with	IN	B-PP	O
confusion	confusion	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
would	would	MD	B-VP	O
restart	restart	VB	I-VP	O
the	the	DT	B-NP	O
Zyprexa	Zyprexa	NNP	I-NP	O
immediately	immediately	RB	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
+2.5	+2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
again	again	RB	B-ADVP	O
off	off	IN	B-PP	O
Zyprexa	Zyprexa	NNP	B-NP	O
,	,	,	O	O
but	but	CC	O	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
only	only	RB	I-VP	O
been	be	VBN	I-VP	O
discontinued	discontinue	VBN	I-VP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
he	he	PRP	B-NP	O
may	may	MD	B-VP	O
well	well	RB	I-VP	O
need	need	VB	I-VP	O
this	this	DT	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
added	add	VBN	I-VP	O
on	on	RP	B-PRT	O
.	.	.	O	O

As	As	RB	B-ADVP	O
soon	soon	RB	I-ADVP	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
Zyprexa	Zyprexa	NNP	I-NP	O
is	be	VBZ	B-VP	O
added	add	VBN	I-VP	O
on	on	IN	B-PP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
cleared	clear	VBN	I-VP	O
his	his	PRP$	B-NP	O
delirium	delirium	NN	I-NP	O
pretty	pretty	RB	B-ADVP	O
quickly	quickly	RB	I-ADVP	O
,	,	,	O	O
so	so	RB	B-NP	O
this	this	DT	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
quite	quite	RB	B-ADJP	O
effective	effective	JJ	I-ADJP	O
for	for	IN	B-PP	O
him	him	PRP	B-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
an	an	DT	B-NP	O
ID	ID	NN	I-NP	O
perspective	perspective	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
rifampin	rifampin	NN	I-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
as	as	RB	I-ADVP	O
well	well	RB	I-ADVP	O
as	as	IN	B-PP	O
his	his	PRP$	B-NP	O
penicillin	penicillin	NN	I-NP	B-protein
2	2	CD	I-NP	I-protein
million	million	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
every	every	DT	B-NP	O
four	four	CD	I-NP	O
hours	hour	NNS	I-NP	O
and	and	CC	O	O
these	these	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
through	through	IN	B-PP	O
12/10/07	12/10/07	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Kerschner	Kerschner	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ID	ID	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
on	on	IN	B-PP	O
8/20/07	8/20/07	CD	B-NP	O
at	at	IN	B-PP	O
8	8	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
a.m.	a.m.	NN	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
these	these	DT	B-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
make	make	VBP	B-VP	O
sure	sure	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
attends	attend	VBZ	B-VP	O
this	this	DT	B-NP	O
appointment	appointment	NN	I-NP	O
as	as	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
important	important	JJ	I-ADJP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
deceptive	deceptive	JJ	B-NP	O
time	time	NN	I-NP	O
running	run	VBG	B-VP	O
any	any	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
completed	complete	VBD	B-VP	O
his	his	PRP$	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Valtrex	Valtrex	NNP	B-NP	O
and	and	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
need	need	VB	I-VP	O
any	any	DT	B-NP	O
further	further	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
Valtrex	Valtrex	NNP	B-NP	O
.	.	.	O	O

Gout	Gout	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
gout	gout	NN	B-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
MCP	MCP	NN	I-NP	O
and	and	CC	I-NP	O
PIP	PIP	NN	I-NP	O
joints	joint	NNS	I-NP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
colchicine	colchicine	NN	I-NP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

This	This	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
for	for	IN	B-PP	O
five	five	CD	B-NP	O
additional	additional	JJ	I-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
he	he	PRP	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
decreased	decrease	VBN	I-VP	O
back	back	RB	B-ADVP	O
down	down	RB	I-ADVP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
down	down	RB	I-ADVP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
foreseeable	foreseeable	JJ	I-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
an	an	DT	B-NP	O
FEN	FEN	NN	I-NP	O
perspective	perspective	NN	I-NP	O
,	,	,	O	O
Nutrition	Nutrition	NN	B-NP	O
was	be	VBD	B-VP	O
following	follow	VBG	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
his	his	PRP$	B-NP	O
phosphorous	phosphorous	JJ	I-NP	O
checked	check	VBD	B-VP	O
regularly	regularly	RB	B-ADVP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
have	have	VBP	B-VP	O
assistance	assistance	NN	B-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
meals	meal	NNS	I-NP	O
as	as	RB	B-ADVP	O
much	much	RB	I-ADVP	O
as	as	IN	B-PP	O
possible	possible	JJ	B-ADJP	O
so	so	IN	B-SBAR	O
that	that	IN	I-SBAR	O
he	he	PRP	B-NP	O
can	can	MD	B-VP	O
eat	eat	VB	I-VP	O
as	as	RB	B-NP	O
much	much	RB	I-NP	O
as	as	IN	B-PP	O
possible	possible	JJ	B-ADJP	O
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
hyponatremia	hyponatremia	NN	I-NP	O
perspective	perspective	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
sodium	sodium	NN	I-NP	O
was	be	VBD	B-VP	O
improved	improve	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
fact	fact	NN	B-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
sodium	sodium	NN	I-NP	O
was	be	VBD	B-VP	O
132	132	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
free	free	JJ	B-NP	O
water	water	NN	I-NP	O
restriction	restriction	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
King	King	NNP	I-NP	O
Ch	Ch	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
as	as	IN	B-PP	O
his	his	PRP$	B-NP	O
hyponatremia	hyponatremia	NN	I-NP	O
is	be	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
from	from	IN	B-PP	O
hypervolemic	hypervolemic	JJ	B-NP	O
hyponatremia	hyponatremia	NN	I-NP	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
low	low	JJ	I-NP	O
albumin	albumin	NN	I-NP	O
and	and	CC	O	O
poor	poor	JJ	B-NP	O
oncotic	oncotic	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

Code	Code	NNP	B-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
discharge	discharge	NN	I-NP	O
addendum	addendum	NN	I-NP	O
.	.	.	O	O

TO	TO	TO	B-PP	O
DO	DO	NNP	B-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
make	make	VBP	B-VP	O
sure	sure	JJ	B-ADJP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continues	continue	VBZ	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
through	through	IN	B-PP	O
7/4/07	7/4/07	CD	B-NP	O
also	also	RB	B-ADVP	O
make	make	VBP	B-VP	O
sure	sure	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
sees	see	VBZ	B-VP	O
Trey	Trey	NNP	B-NP	O
Kachmarsky	Kachmarsky	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ID	ID	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
on	on	IN	B-PP	O
8/20/07	8/20/07	CD	B-NP	O
at	at	IN	B-PP	O
8	8	CD	B-NP	O
a.m.	a.m.	RB	I-NP	O
Please	Please	NNP	I-NP	O
also	also	RB	B-ADVP	O
make	make	VBP	B-VP	O
sure	sure	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
sees	see	VBZ	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Ronald	Ronald	NNP	I-NP	O
Treiber	Treiber	NNP	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Fullming	Fullming	NNP	I-NP	O
Skaggs	Skaggs	NNP	I-NP	O
Ingoernstrong	Ingoernstrong	NNP	I-NP	O
Rid	Rid	NNP	I-NP	O
Health	Health	NNP	I-NP	O
on	on	IN	B-PP	O
4/15/07	4/15/07	CD	B-NP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
p.m.	p.m.	RB	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Dr.	Dr.	NNP	B-NP	O
Milton	Milton	NNP	I-NP	O
Fiero	Fiero	NNP	I-NP	O
on	on	IN	B-PP	O
2/5/07	2/5/07	CD	B-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
a.m.	a.m.	RB	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Criqui	Criqui	NNP	I-NP	O
following	follow	VBG	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
Faxventci	Faxventci	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Heparin	Heparin	NN	B-NP	B-protein
5000	5000	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
which	which	WDT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
from	from	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

NovoLog	NovoLog	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
as	as	IN	B-PP	O
per	per	IN	B-PP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
premeals	premeal	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Synthroid	Synthroid	JJ	B-NP	O
75	75	CD	I-NP	O
mcg	mcg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Nephrocaps	Nephrocaps	RB	B-NP	O
1	1	CD	I-NP	O
tab	tab	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Zyprexa	Zyprexa	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
every	every	DT	B-NP	O
twelve	twelve	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
agitation	agitation	NN	B-NP	O
or	or	CC	I-NP	O
delirium	delirium	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Omeprazole	Omeprazole	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Penicillin	Penicillin	NNP	B-NP	O
G	G	NNP	I-NP	O
2	2	CD	I-NP	O
million	million	CD	I-NP	O
units	unit	NNS	I-NP	O
IV	IV	CD	B-NP	O
every	every	DT	B-NP	O
4	4	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Prednisone	Prednisone	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
24	24	CD	I-NP	O
hours	hour	NNS	I-NP	O
for	for	IN	B-PP	O
five	five	CD	B-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	O	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
24	24	CD	I-NP	O
hours	hour	NNS	I-NP	O
for	for	IN	B-PP	O
five	five	CD	B-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	O	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
24	24	CD	I-NP	O
hours	hour	NNS	I-NP	O
permanently	permanently	RB	B-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Rifampin	Rifampin	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Senna	Senna	NNP	B-NP	O
2	2	CD	I-NP	O
tabs	tab	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Flomax	Flomax	NN	B-NP	O
0.8	0.8	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Ultram	Ultram	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
every	every	DT	B-NP	O
twelve	twelve	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Effexor	Effexor	NN	B-NP	O
extended	extend	VBD	B-VP	O
release	release	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
after	after	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

ConvaTec	ConvaTec	NNP	B-NP	O
Aquacel	Aquacel	NNP	I-NP	O
silver	silver	NN	I-NP	O
one	one	CD	I-NP	O
topical	topical	JJ	B-VP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
remember	remember	NN	B-NP	O
to	to	TO	B-VP	O
avoid	avoid	VB	I-VP	O
narcotics	narcotic	NNS	B-NP	O
and	and	CC	I-NP	O
benzodiazepines	benzodiazepine	NNS	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
sensitive	sensitive	JJ	I-ADJP	O
to	to	TO	B-PP	O
medicines	medicine	NNS	B-NP	O
and	and	CC	O	O
may	may	MD	B-VP	O
well	well	RB	I-VP	O
developed	develop	VBD	I-VP	O
repeat	repeat	NN	B-NP	O
delirium	delirium	NN	I-NP	O
as	as	IN	B-SBAR	O
has	have	VBZ	B-VP	O
given	give	VBN	I-VP	O
them	them	PRP	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
0-0820611	0-0820611	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
ENGLERTH	ENGLERTH	NNP	B-NP	O
,	,	,	O	O
LEWIS	LEWIS	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HEINITZ	HEINITZ	NN	B-NP	O
,	,	,	O	O
GINO	GINO	NN	B-NP	O
Dictation	Dictation	NN	I-NP	O
ID	ID	NN	I-NP	O
1307654	1307654	CD	I-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
7/28/07	7/28/07	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/28/07	7/28/07	CD	B-NP	O

